BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23132232)

  • 1. Renal denervation for treatment-resistant hypertension.
    Mafeld S; Vasdev N; Haslam P
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):245-58. PubMed ID: 23132232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation for resistant hypertension and beyond.
    Laffin LJ; Bakris GL
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal denervation for resistant hypertension treatment: a novel team approach.
    Fajadet J
    EuroIntervention; 2012 Oct; 8(6):655-7. PubMed ID: 23086782
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
    Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M
    EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging anatomy, how to treat or not to treat?
    Zeller T; Rastan A; Macharzina R; Noory E
    EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation as therapy for hypertension: potentials and unanswered questions.
    Vink EE; Bots ML; Blankestijn PJ
    Eur J Prev Cardiol; 2013 Dec; 20(6):980-91. PubMed ID: 23610453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation: a plea for wisdom.
    Lantelme P; Courand PY; Pathak A
    Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
    [No Abstract]   [Full Text] [Related]  

  • 10. Current technologies: an introduction.
    Daemen J
    EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D; Figulla HR; Surber R
    Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated ESH position paper on interventional therapy of resistant hypertension.
    Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C;
    EuroIntervention; 2013 May; 9 Suppl R():R58-66. PubMed ID: 23732157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant hypertension in 2017.
    Hans S; Reilly JP
    Curr Opin Cardiol; 2017 Jul; 32(4):389-396. PubMed ID: 28505045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation in the management of resistant hypertension: current evidence and perspectives.
    Jin Y; Persu A; Staessen JA
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):511-8. PubMed ID: 23892701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal denervation in hypertension: simplicity, or complexity?
    Lantelme P; Courand PY; Bricca G
    Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    Epstein M; de Marchena E
    J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sympathetic denervation and systemic hypertension.
    Doumas M; Faselis C; Papademetriou V
    Am J Cardiol; 2010 Feb; 105(4):570-6. PubMed ID: 20152255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.